This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on may 12, 2016.Method: photographic inspection; manufacturing review; results: improper physical structure.Conclusions: human factors issue ; device not returned.The actual device was not returned for evaluation; however, a photograph of the event was provided by the user facility.Upon inspection of the provided photo, it was confirmed that the small sampling or purge line had a partial cut through the tubing.Without the device returned, a definitive root cause could not be determined.Review of the device history records revealed no manufacturing issues.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|